Johns Hopkins HIV Guide
Doravirine
INDICATIONS
FDA
FDA
- Treatment of HIV in treatment-naive adult patients in combination with other ART
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: March 5, 2019
Citation
Smith, Janessa M. "Doravirine." Johns Hopkins HIV Guide, The Johns Hopkins University, 2019. Johns Hopkins Guides, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545274/5/Doravirine.
Smith JM. Doravirine. Johns Hopkins HIV Guide. The Johns Hopkins University; 2019. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545274/5/Doravirine. Accessed October 8, 2025.
Smith, J. M. (2019). Doravirine. In Johns Hopkins HIV Guide. The Johns Hopkins University. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545274/5/Doravirine
Smith JM. Doravirine [Internet]. In: Johns Hopkins HIV Guide. The Johns Hopkins University; 2019. [cited 2025 October 08]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545274/5/Doravirine.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Doravirine
ID - 545274
A1 - Smith,Janessa,PharmD, BCPS
Y1 - 2019/03/05/
BT - Johns Hopkins HIV Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545274/5/Doravirine
PB - The Johns Hopkins University
DB - Johns Hopkins Guides
DP - Unbound Medicine
ER -
